Hull University Teaching Hospitals NHS Trust Deploys DXC Technology’s Mobile App
News Release -- November 04, 2020
DXC Clinical Aide app enables staff to access patient information without the need to enter high-risk hospital areas
London, 4 November 2020 - Hull University Teaching Hospitals NHS Trust has deployed DXC Technology’s (NYSE:DXC) Clinical Aide mobile application, which both improves secure access to electronic patient medical records and increases patient and hospital staff safety by limiting unneeded contact in higher-risk areas such as COVID-19 wards and intensive care units.
By using a mobile app that sits on top of the Trust’s electronic patient record (EPR) system, clinical teams can now securely view and use important patient information from the Lorenzo EPR, part of the DXC Care Suite, from anywhere via a tablet or other mobile device. Mobile access to a patient’s allergies, problems, observations, medication, results and other documented information reduces the need for staff to enter higher-risk hospital areas to review and update medical records directly on workstations. This enhancement also removes the need to transfer paper-based detailed patient information in or out of the hospital’s COVID-19 wards.
Dr Alastair Pickering, Chief Clinical Information Officer at Hull University Teaching Hospitals NHS Trust, which manages Hull Royal Infirmary and Castle Hill Hospital, said, “The way our clinical workforce is currently deployed requires greater flexibility to access important information. Going to a static device and logging in is now often not practical, and Clinical Aide is allowing clinicians to access results and other crucial information on-the-go, in a way that is much more supportive of current ways of working.”
He added, “There is a significant safety gain in making this information mobile, as some staff are not now required to go into high-risk environments like intensive care units or other wards with COVID patients. Pharmacists and the dietetics team, for example, are now able to review and act on referrals that have come through to their mobile device from any location, meaning they are less likely to expose themselves to infection or need to use the Trust’s personal protective equipment.”
DXC’s Clinical Aide has been rapidly deployed across six hospital wards with COVID-19 patients, with minimal training required. The mobile app is used by a diverse range of healthcare professionals including nurses, dieticians and pharmacists, who can also view patient assessments, ongoing plans and patients’ personal health wishes.
The app provides a flexible approach to accessing the Trust’s locally designed forms to supplement COVID-19 guidance for hospital bereavement teams. Trust clinicians can add detailed patient notes from Clinical Aide into the EPR, for nurses and bereavement team members to access on their mobile device when talking to patients and relatives.
Neil Proudlove, Head of Care Records at Hull University Teaching Hospitals NHS Trust, said that new digital approaches developed in response to coronavirus will soon be expanded. “Responding to COVID-19 is just the beginning,” he said. “The introduction of technology to overcome some of the barriers presented by coronavirus can be applied to the organisation post-COVID.”
He added, “Clinical Aide access has been deployed to hundreds of staff at pace in just a few weeks and has been popular with clinicians, who have access to results as soon as they become available and who don’t need to go back to base to view important information in the EPR. We plan to deliver Clinical Aide to more of our 8,900 staff, and to make it even more comprehensive as a tool. One of the main aims would be to use the mobile technology to support ward rounds and medical handover processes.” Combined with the integrated use of other mobile apps, he said, the Trust plans to progress its digital maturity through these flexible ways of working.
Colin Henderson, Director of Healthcare and Life Sciences for the UK, Ireland, Israel, Middle East and Africa (UKIIMEA) at DXC Technology, said, “This is a good example of quickly deploying a helpful utility, giving the users a seamless, secure way of seeing vital information in a mobile form. Speed and ease of deployment was an important factor given the climate we were in, and it’s great to receive such positive feedback from the front line.”
On July 20, 2020, DXC Technology announced the sale of its healthcare provider software business to the Dedalus Group to create one of the world’s leading, vertically focused healthcare IT businesses and to advance DXC’s strategy of unlocking value, serving customers and growing its business across the Enterprise Technology Stack.
About DXC Technology
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy our enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences. Learn more about the DXC story and our focus on people, customers and operational execution at www.dxc.technology.
Background on DXC in UK Healthcare
DXC maintains more than 100 million electronic health records and provides an extensive range of clinical and non-clinical solutions and services to NHS Trusts in England. Through the use of digital technology, DXC works with the NHS to deliver new models of care and enable better healthcare outcomes. This includes the delivery of care co-ordination, end-to-end health and care system transformation, robotics and artificial intelligence.
DXC Care Suite is a health platform and intelligent patient administration system that offers contemporary patient record management, automated scheduling and pathway management. The interoperability capabilities of DXC Open Health Connect helps care providers integrate data from different systems to create a longitudinal patient record via Fast Healthcare Interoperability Resources (FHIR) interfaces. DXC Care Suite supports the digital experience of the patient-individual and delivers a comprehensive cross-sectoral patient record to enable high-quality care across healthcare silos.
For more information, visit DXC Care Suite
Cautionary Note Regarding Forward-looking Statements
All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent DXC’s intentions, plans, expectations and beliefs, and are subject to risks, uncertainties and other factors many of which are outside DXC’s control. Many factors could cause actual results to differ materially from such forward-looking statements with respect to the transaction announced above, including risks relating to: the completion of the transaction on anticipated timing, including obtaining regulatory and third-party approvals; conditions in the credit markets; anticipated tax treatment for the proposed transaction; unforeseen liabilities; loss of revenues; the potential impact of announcement or consummation of the proposed transaction on relationships with third parties, including clients, employees and competitors; and the delay or business disruption caused by difficulties in separating the divested business from DXC’s remaining businesses. For a written description of the factors that could cause actual results of DXC’s business to differ materially from these forward-looking statements, see the section titled “Risk Factors” in DXC’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020, as updated in subsequent SEC filings including the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, which readers are urged to review in detail, as it contains important information regarding risks, uncertainties and other factors that could cause actual results to differ from the plans, expectations and other matters described in this press release. No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. DXC disclaims any intention or obligation to update these forward-looking statements whether as a result of subsequent events or otherwise, except as required by law.